Cargando…
Cyclic rifaximin therapy effectively prevents the recurrence of symptoms after exacerbation of symptomatic uncomplicated diverticular disease: a retrospective study
INTRODUCTION: Symptomatic uncomplicated diverticular disease (SUDD) is the most common manifestation of diverticulosis. Data concerning the optimal treatment after SUDD exacerbation are inconsistent. AIM: To assess the effectiveness and necessity of cyclic rifaximin treatment for recurrent SUDD symp...
Autores principales: | Pietrzak, Anna M., Dziki, Adam, Banasiewicz, Tomasz, Reguła, Jarosław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444108/ https://www.ncbi.nlm.nih.gov/pubmed/30944680 http://dx.doi.org/10.5114/pg.2019.83428 |
Ejemplares similares
-
Diagnosis of symptomatic uncomplicated diverticular disease and the role of Rifaximin in management
por: Maconi, Giovanni
Publicado: (2017) -
Gut Microbiota and Related Electronic Multisensorial System Changes in Subjects With Symptomatic Uncomplicated Diverticular Disease Undergoing Rifaximin Therapy
por: De Vincentis, Antonio, et al.
Publicado: (2021) -
Eubiotic effect of rifaximin is associated with decreasing abdominal pain in symptomatic uncomplicated diverticular disease: results from an observational cohort study
por: Ivashkin, Vladimir, et al.
Publicado: (2023) -
Uncomplicated Diverticular Disease: Innate and Adaptive Immunity in Human Gut Mucosa before and after Rifaximin
por: Cianci, Rossella, et al.
Publicado: (2014) -
Ultrasonographic and Functional Features of Symptomatic Uncomplicated Diverticular Disease
por: Maconi, Giovanni, et al.
Publicado: (2023)